Big Pharma May Not Be Able to Scoop Up This Biotech

A biotechnology company has developed "what could turn out to be one of the most important cancer drugs in a generation," writes David Wainer for the Wall Street Journal —in a piece that focuses less on the drug and more on the fact that Revolution Medicines may now be too...